Lower negative symptom scores among cannabis-dependent patients with schizophrenia-spectrum disorders: preliminary evidence from an African American first-episode sample

Schizophrenia Research
Michael T ComptonNadine J Kaslow

Abstract

Substance use disorders, especially cannabis abuse and dependence, are common comorbid diagnoses among patients in the early course of schizophrenia. Some prior research suggests that individuals with schizophrenia and related disorders and comorbid substance abuse may have fewer negative symptoms than those without substance abuse. This pilot study examined the association between cannabis dependence and negative symptoms in a relatively homogenous sample of 18 African American first-episode, first-hospitalization patients. Those with cannabis dependence had significantly lower Positive and Negative Syndrome Scale (PANSS) negative subscale scores compared to those without cannabis dependence (p<0.012). The two groups did not differ on PANSS positive and general psychopathology subscale scores. Additional research is needed on the correlates of substance abuse among first-episode patients, including socially disadvantaged African American patients.

References

Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Feb 1, 1994·The Journal of Nervous and Mental Disease·P LysakerR Milstein
May 1, 1996·Schizophrenia Research·B KirkpatrickT McGlashan
Apr 22, 1999·The British Journal of Psychiatry : the Journal of Mental Science·R CantwellG Harrison
Sep 1, 2001·Psychiatric Rehabilitation Journal·J Addington, D Addington
Apr 16, 2003·Schizophrenia Bulletin·Geraldine Scheller-GilkeyAndrew H Miller
Jul 3, 2003·Schizophrenia Research·Brian KirkpatrickCenk Tek
Sep 6, 2003·Schizophrenia Research·Christian C JoyalSheilagh Hodgins
Nov 25, 2003·Schizophrenia Research·William P Horan, Jack J Blanchard

❮ Previous
Next ❯

Citations

Mar 15, 2015·Current Addiction Reports·Samuel T WilkinsonDeepak Cyril D'Souza
Jun 25, 2014·Molecular Psychiatry·R A PowerN G Martin
May 6, 2014·European Archives of Psychiatry and Clinical Neuroscience·Inge GoryniaAndreas Heinz
Jun 2, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Cécile HenquetInez Myin-Germeys
Aug 30, 2008·Schizophrenia Bulletin·Cécile HenquetRobin M Murray
Apr 24, 2009·Schizophrenia Bulletin·Johanna KoskinenJouko Miettunen
Aug 21, 2007·Journal of Psychoactive Drugs·Mohamed Ben Amar, Stéphane Potvin
May 12, 2011·Psychological Medicine·J E HoustonG Adamson
Sep 25, 2010·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Monica RaisRené S Kahn
Jul 22, 2009·Journal of Psychiatric Research·Chun-Jung HuangEl-Wui Loh
Jan 1, 2011·Journal of Dual Diagnosis·Jennifer P Wisdom, Jennifer I Manuel
Apr 21, 2009·Acta Psychiatrica Scandinavica·J KoskinenJ Miettunen
Oct 15, 2009·Acta Psychiatrica Scandinavica·R MazzonciniP Fearon
Jun 6, 2006·Schizophrenia Research·A TalamoR J Baldessarini
May 21, 2010·Schizophrenia Research·Pamela DeRosseAnil K Malhotra
Jun 18, 2010·Journal of Psychiatric Research·Bart D PetersLieuwe de Haan
Jan 19, 2016·L'Encéphale·N SimonJ-M Azorin
Apr 9, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Alexandre SeillierAndrea Giuffrida
Jan 5, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Romina MizrahiPablo Rusjan
Jul 13, 2013·Journal of Religion and Health·Jennifer Shepard Payne
Oct 18, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ferenc ZádorLászló Vécsei

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Archives of Psychiatry and Clinical Neuroscience
G BersaniP Pancheri
The American Journal of Psychiatry
Natalie D VeenRené S Kahn
European Archives of Psychiatry and Clinical Neuroscience
D Caspari
© 2021 Meta ULC. All rights reserved